Clinical trial reports

  • Which EU Sites Lead Head and Neck Cancer Phase I–III Trials?
  • Which CROs Are Most Active in European Heart Failure Phase II and Phase III Trials?
  • Is Overall Survival Still the Primary Endpoint Anchor in European Phase III Gastric Cancer Trials?
  • Which Endpoints Are Most Frequently Measured in European Gastroenterology Phase II and Phase III Trials?
  • What Drives Phase I Cell Therapy CTIS Timelines and Delays?
  • Which CROs Are Most Active in European Phase II–III Multiple Myeloma Trials?
  • Which Endpoints Are Most Frequently Measured in European Haematology Phase II & III Trials?
  • Which CROs Are Most Active in European Radiopharmaceutical Phase 1 - 3 CTIS Trials?
  • Which CROs Support Lymphoma Phase II–III Trials in Europe, and When Are They Used Most?
  • Which CROs Are Most Active in European Gastric and Esophageal Phase II/III Trials?
  • Which endpoints dominate European Phase II and III melanoma clinical trials?
  • Which CROs Are Most Active in European Respiratory Phase III Trials, and Where Is CRO Capacity Needed Most?